Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dabigatran versus warfarin in patients with mechanical heart valves.
Eikelboom JW, Connolly SJ, Brueckmann M, Granger CB, Kappetein AP, Mack MJ, Blatchford J, Devenny K, Friedman J, Guiver K, Harper R, Khder Y, Lobmeyer MT, Maas H, Voigt JU, Simoons ML, Van de Werf F; RE-ALIGN Investigators. Eikelboom JW, et al. Among authors: khder y. N Engl J Med. 2013 Sep 26;369(13):1206-14. doi: 10.1056/NEJMoa1300615. Epub 2013 Aug 31. N Engl J Med. 2013. PMID: 23991661 Free article. Clinical Trial.
Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy.
Verheugt FW, Clemmensen P, Mehran R, Agewall S, Pocock SJ, Goldstein S, Torp-Pedersen C, Simoons ML, Borer JS, Khder YM, Burton P, Deliargyris E, McMurray JJ, Berkowitz SD, Stough WG, Zannad F. Verheugt FW, et al. Among authors: khder ym. Eur Heart J. 2013 Jun;34(22):1621-9. doi: 10.1093/eurheartj/eht013. Epub 2013 Feb 4. Eur Heart J. 2013. PMID: 23382466 No abstract available.
The effect of sacubitril/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study.
Schmieder RE, Wagner F, Mayr M, Delles C, Ott C, Keicher C, Hrabak-Paar M, Heye T, Aichner S, Khder Y, Yates D, Albrecht D, Langenickel T, Freyhardt P, Janka R, Bremerich J. Schmieder RE, et al. Among authors: khder y. Eur Heart J. 2017 Nov 21;38(44):3308-3317. doi: 10.1093/eurheartj/ehx525. Eur Heart J. 2017. PMID: 29029087 Free article. Clinical Trial.
Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
Lacourcière Y, Poirier L, Hebert D, Assouline L, Stolt P, Rehel B, Khder Y. Lacourcière Y, et al. Among authors: khder y. Clin Ther. 2005 Jul;27(7):1013-21. doi: 10.1016/j.clinthera.2005.07.010. Clin Ther. 2005. PMID: 16154480 Clinical Trial.
Sacubitril/Valsartan (LCZ696) in Heart Failure.
Khder Y, Shi V, McMurray JJV, Lefkowitz MP. Khder Y, et al. Handb Exp Pharmacol. 2017;243:133-165. doi: 10.1007/164_2016_77. Handb Exp Pharmacol. 2017. PMID: 28004291 Review.
19 results